Integrating ESR1m Testing and Novel Oral SERDS Into Multidisciplinary Workflows: Regional Guidance for HR+, HER2- Advanced Breast Cancer

0:00-1:03:07

Please visit answersincme.com/860/101707775-replay2 to participate, download slides and supporting materials, complete the post test, and get a certificate. [Presented by Erika Hamilton, MD, FASCO; Komal Jhaveri, MD, FACP, FASCO; and John Allen Piede, MD. In this activity, experts in breast cancer provide a practical, community-focused discussion on integrating ESR1 mutation testing, applying emerging data on novel endocrine therapies, such as SERDs, and personalizing treatment strategies for patients with HR+, HER2− advanced breast cancer. Upon completion of this activity, participants should be better able to: Integrate testing for ESR1 mutations at appropriate times into practice workflows in the treatment of...

Publisher

CME in Minutes: Education in Oncology & Hematology

Link

answersincme.com/860/101707775-replay2

Published

August 4, 2026

Duration

1h 3m

Format

Podcast

Category

Lifestyle · Medicine

Source

RSS feed

Host

Answers in CME

CI

CME in Minutes: Education in Oncology & Hematology

@cmeinminuteseducationinoncol

#integratingesr1mtesting #noveloralserds #advancedbreastcancer #lifesciences #medicine

The Nile